1-16 of 16
Keywords: CA 125
Close
Sort by
Journal Articles
Journal Articles
Subject Area:
Oncology
Tumor Biology (1994) 15 (6): 361–367.
Published Online: 30 April 2009
.... The results were compared with the serum levels of the CA 125 antigen. At a cutoff level of 135 U/l for TPS and 20 U/l for CA 125 (95th percentile of the healthy controls), the sensitivity of the tests for detecting a malignant tumor was 77% for TPS and 87% for CA 125. The specificities were 85% for TPS...
Journal Articles
Subject Area:
Oncology
Tumor Biology (1989) 10 (2): 109–116.
Published Online: 29 April 2009
...P. Benedetti Panici; G. Scambia; G. Baiocchi; C. Sonsini; S. Greggi; F. Battaglia; S. Mancuso Serum levels of CA 19-9, CA 125 and CA 15-3 were measured in 91 patients with cervical cancer (16 with intraepithelial neoplasia and 75 with invasive cancer). In 35 patients with locally advanced cervical...
Journal Articles
Subject Area:
Oncology
Tumor Biology (1988) 9 (1): 47–52.
Published Online: 28 April 2009
...J. Mezger; W. Wilmanns; R. Lamerz The tumor-associated antigen CA 125 is widely used in monitoring of ovarian carcinomas. As this determinant is also expressed in proliferating mesothelia, we studied CA 125 levels in serum and effusion fluid of patients with ascitic and pleural effusions. Patients...
Journal Articles
Subject Area:
Oncology
Tumor Biology (2008) 29 (1): 9–17.
Published Online: 23 May 2008
... U/ml for CA 15-3 (n = 11, 14.1%) and 30 U/ml for CA 125 (n = 10, 12.8%). Stage IB patients with positive SCC-Ag and CYFRA 21-1 had significantly lower OS (mean 8.3 years, 95% confidence interval, CI, 5.8–10.7 years) and DFS (mean 7.3 years, 95% CI 4.6–10 years) than all other stage IB patients (OS...
Journal Articles
Journal Articles
Subject Area:
Oncology
Tumor Biology (2003) 24 (4): 165–171.
Published Online: 08 December 2003
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Antibody ISOBM workshops Tumor markers CA 125 AFP PSA MUC1 Cytokeratins Sialyl Lewis hCG CEA ALP SCC S100 Research Commentary Tumor...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Tumor Biology (2001) 22 (6): 345–347.
Published Online: 24 December 2001
...Eivind Hovig; Phil D. Rye; David J. Warren; Kjell Nustad CA 125, a high-molecular-weight mucin, was first defined in 1981 by the monoclonal antibody OC125. Until recently, it has defied many attempts to purify it from a variety of sources, although many research groups have successfully raised...
Journal Articles
Subject Area:
Oncology
Tumor Biology (2001) 22 (4): 223–228.
Published Online: 01 June 2001
...Lars F. Norum; Bjørn Erikstein; Kjell Nustad The serum tumor markers CA 125, MUC1 and CEA were measured in 221 breast cancer patients over a period of 2 years. Patients examined on at least three occasions were included in the study. Thirty-three patients had increasing or continuously high...
Journal Articles
Subject Area:
Oncology
Tumor Biology (2000) 21 (6): 375–380.
Published Online: 25 September 2000
... of CA 125, CA 19-9, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC), in addition to clinical status at the time of recurrence were investigated. Results: Among the 32 patients, 26 had no symptoms at the time of recurrence. In 20 patients, elevated serum levels of tumor markers...
Journal Articles
Subject Area:
Oncology
Tumor Biology (1999) 20 (3): 117–129.
Published Online: 22 April 1999
... the CEA assays gave a parallel response in individual patients, but the sensitivity was lower compared to BR-MA/CA 15-3. IMMULITE OM-MA was compared to CIS ELSA CA 125 in 208 sera from 32 longitudinally followed ovarian cancer patients. In the majority of patients, a parallel response was observed; lower...
Journal Articles
Subject Area:
Oncology
Tumor Biology (1998) 19 (6): 439–444.
Published Online: 16 November 1998
...) (n = 78) was raised in 35%; carcinoembryonic antigen (CEA) (n = 34) was raised in 26% and CA 125 (n = 64) was raised in 27% of these patients. In 47 of these 91 patients (52%), 1 or more of the markers were raised. The percentage of patients with raised TM increased with advancing stage. Univariate...
Journal Articles
Subject Area:
Oncology
Tumor Biology (1998) 19 (4): 269–274.
Published Online: 06 July 1998
... of recommendations provided by guidelines and to provide the means to verify their rate of acceptance. Tumor markers CA 125 Ovarian cancer Original Paper Tumor Biol 1998;19:269 274 Received: July 18, 1997 Accepted after revision: December 11, 1997 M. Giona P. Barioli a A. Ponti b V. Torri c R. Mione a R...
Journal Articles
Subject Area:
Oncology
Tumor Biology (1998) 19 (3): 160–166.
Published Online: 18 April 1998
... < 0.001). Serum levels were positively related to the extent of the disease. Disease progression was associated with rising serum levels of IL-2Rα in 13 of the 15 patients but no advantage was recognized over serum CA 125 measurements when following the effect of therapy. We measured higher levels of IL...